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 Table 1: The 20 Participating Cohorts of European Ancestry and their Sample Sizes. Cohorts are 
divided into two groups (population-based and family-based) and ordered with respect to sample 






 Yes No % Yes Yes No % Yes 
Population CROATIA-Korcula 456 112 344 24.6% 237 219 52.0% 
 CROATIA-Vis 483 141 342 29.2% 277 206 57.3% 
 BioMe 1,480 134 1,346 9.1% 441 1,039 29.8% 
 CARDIA 1,649 406 1,243 24.6% 693 956 42.0% 
 HealthABC 1,662 106 1,556 6.4% 951 711 57.2% 
 RS2 1,998 408 1,590 20.4% 1,410 588 70.6% 
 AGES 2,410 345 2,065 14.3% 1,440 970 59.8% 
 MESA 2,591 298 2,293 11.5% 1,447 1,144 55.8% 
 RS3 2,966 673 2,293 22.7% 2,031 935 68.5% 
 CHS 2,975 357 2,618 12.0% 1,595 1,380 53.6% 
 RS1 4,991 1,162 3,829 23.3% 3,317 1,674 66.5% 
 GS:SFHS* 6,439 994 5,445 15.4% 3,133 3,306 48.7% 
 ARIC 9,465 2,339 7,126 24.7% 5,685 3,780 60.1% 
 WGHS 22,983 2,680 20,303 11.7% 11,284 11,699 49.1% 
Family HERITAGE 499 75 424 15.0% 191 308 38.3% 
 GENOA 1,064 169 895 15.9% 535 529 50.3% 
 HyperGEN 1,251 114 1,137 9.1% 424 827 33.9% 
 ERF 2,491 984 1,507 39.5% 1,721 770 69.1% 
 FamHS 3,683 523 3,160 14.2% 1,668 2,015 45.3% 
 FHS 8,195 2,520 5,675 30.8% 4,281 3,914 52.2% 
 Total 79,731 14,540 65,182 18.2% 42,761 36,970 53.6% 
Abbreviations: BioMe, Biobank of Institute for Personalized Medicine at Mount Sinai; 
CARDIA, Coronary Artery Risk Development in Young Adults; HealthABC, Health, Aging, and 
Body Composition study;RS2, Rotterdam Study cohort 2; AGES, Age Gene Environment 
Susceptibility Study; MESA, Multi-Ethnic Study of Atherosclerosis;RS3, Rotterdam Study 
cohort 3;CHS, Cardiovascular Health Study;RS1, Rotterdam Study cohort 1;GS:SFHS, 
Generation Scotland Scottish Family Health Study; ARIC, Atherosclerosis Risk in 
Communities;WGHS, Women’s Genome Health Study; HERITAGE, Health, Risk Factors, 
Exercise Training and Genetics;GENOA, Genetic Epidemiology Network of Arteriopathy; 
HyperGEN, Hypertension Genetic Epidemiology Network; ERF,Erasmus Rucphen Family 
study; FamHS, Family Heart Study; FHS, Framingham Heart Study 
*For this manuscript, GS:SFHS, although a family-based study, removed related individuals 
using IBS values calculated from genetic data.
  
Table 2:Correlation between the two frameworks for cohort-specific GWAS results. Scatterplots 




  1DF 2DF 1DF 2DF 
Population CROATIA-Korcula 0.943 0.942 0.973 0.950 
 CRO-Vis 0.951 0.927 0.970 0.923 
 BioMe 0.984 0.990 0.994 0.995 
 CARDIA 0.968 0.976 0.996 0.997 
 HealthABC 0.993 0.994 0.998 0.998 
 RS2 0.992 0.994 0.999 0.999 
 AGES 0.997 0.998 0.999 0.999 
 MESA 0.977 0.986 0.990 0.993 
 RS3 0.998 0.999 1.000 1.000 
 CHS 0.991 0.994 0.999 0.999 
 RS1 0.996 0.998 0.996 0.997 
 GS:SFHS 0.978 0.980 0.995 0.991 
 ARIC 0.992 0.994 0.992 0.993 
  WGHS 0.999 1.000 1.000 1.000 
Family HERITAGE 0.762 0.819 0.886 0.902 
 GENOA 0.998 0.998 0.992 0.992 
 HyperGEN 0.885 0.921 0.935 0.942 
 ERF 0.973 0.979 0.974 0.979 
 FamHS 0.926 0.950 0.960 0.968 
  FHS 0.935 0.951 0.939 0.951 
 
  
Table 3:Spearman rank correlation coefficients between the two stratum-specific genetic effects 
calculated from the genome-wide resultsused for the 1 DF test in the stratified framework 
 Cohort CurSmk EverSmk 
Cohort-level for CROATIA-Korcula 0.000 -0.003 
population-based CROATIA-Vis 0.014 0.005 
cohorts BioMe 0.001 0.002 
 CARDIA 0.000 -0.002 
 HealthABC 0.007 0.010 
 RS2 0.003 -0.001 
 AGES 0.016 0.014 
 MESA 0.012 0.044 
 RS3 0.006 0.006 
 CHS 0.001 0.004 
 RS1 0.013 0.005 
 GS:SFHS 0.003 0.006 
 ARIC 0.012 0.012 
 WGHS 0.014 0.027 
Cohort-level for  HERITAGE 0.105 0.076 
family-based GENOA 0.017 0.030 
cohorts HyperGEN 0.052 0.093 
 ERF 0.053 0.066 
 FamHS 0.071 0.078 
 FHS 0.091 0.112 
Meta-level Population-based cohorts 0.034 0.045 
 Family-based cohorts 0.090 0.095 
 All cohorts 0.055 0.065 
 
  
Table 4: Correlation between the two frameworks for meta-analysis results. Scatterplots are 






1DF 2DF 1DF 2DF 
Scheme A Population cohorts 0.942 0.970 0.950 0.982 
 Family cohorts 0.860 0.893 0.889 0.924 
 All cohorts 0.904 0.947 0.927 0.965 
Scheme B Population cohorts 0.957 0.990 0.965 0.995 
 Family cohorts 0.882 0.946 0.905 0.950 
 All cohorts 0.923 0.98 0.948 0.985 
 
  
Table 5:Comparison of schemes A and B for family-based meta-analysis forCurSmk at select 
variants 



















Meta Scheme A 4,479   12.8 1.0 7.8E-41 8.5E-40  
Meta Scheme B 3,160   0.6 2.7 0.83 0.63 0.89 
Cohort FamHS 3,160 77.7 13.7 0.6 2.6 0.83 0.60 0.89 
Cohort GENOA 895 29.9 <10 3.2 3.1 0.30   
Cohort HERITAGE 424 10.3 <10 15.8 1.0 1.2E-54   
6:142093034 
(MAF=1.7%) 
Meta Scheme A 12,798   4.7 0.5 3.8E-23 2.2E-22  
Meta Scheme B 10,342   -0.1 1.0 0.89 0.47 0.61 
Cohort ERF 1,507 66.9 52.7 1.2 2.1 0.58 0.68 0.78 
Cohort FamHS 3,160 140.3 25.2 0.2 1.6 0.88 0.98 0.89 
Cohort FHS 5,675 141.8 63.0 -0.5 1.5 0.74 0.47 0.5 
Cohort GENOA 895 43.8 <10 -4.0 2.6 0.12 0.15 0.12 
Cohort HERITAGE 424 19.1 <10 -6.3 0.5 1.9E-33   
Cohort HyperGEN 1137 30.5 <10 0.3 4.4 0.95   
12:5679139 
(MAF=1.3%) 
Meta Scheme A 4,479   1.9 2.1 0.37 1.8E-09  
Meta Scheme B 3,160   4.1 2.8 0.15 5.0E-09 1.9E-11 
Cohort FamHS 3,160 84.1 12.5 -4.1 2.8 0.14 6.3E-10 3.8E-12 
Cohort GENOA 895 33.5 <10 3.1 3.7 0.41 0.2 0.21 
Cohort HERITAGE 424 10.5 <10 -3.6 4.8 0.46 0.59 2.4E-08 
 
